Coronary artery disease in patients with renal failure

International Journal of Clinical Practice

Volumn 55, Issue 3, 2001, Pages 196-210

  Goldsmith, Dja ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b CI Parhon Hospital   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEPARIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; VERAPAMIL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIALYSIS; ELECTROCARDIOGRAPHY; ELECTRON BEAM TOMOGRAPHY; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HEART VALVE SURGERY; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; OXIDATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STRESS ECHOCARDIOGRAPHY; SYMPTOMATOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035034526     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (229)

1. Raine AE, Margreiter R, Brunner FP el al. Report on management of renal failure in Europe, XXII. 1991. Nephrol Dial Transplant 1992; 7(suppl 2): 7-35.
2. Jungers P, Nguyen KT, Massy ZA, Man NK. Incidence of atherosclerotic cardiovascular events in patients with chronic uraemia: epidemiologic studies in Ile-de-France. Nephrologie 1998; 19(8): 489-494.
3. Brown JH, Hunt LP, Vites NP et al. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994; 9: 1136-1142.
4. Kumar S, Merchant MR, Dyer P et al. Increased mortality due to cardiovascular disease in type 1 diabetic patients transplanted for end-stage renal failure. Diabei Med 1994; 11(10): 987-991.
5. Lindholm A, Albrechtsen D, Frodin L et al. Ischemie heart disease: major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60(5): 451-457.
6. Kasiske BL, Guijarro C, Massy ZA et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7(1): 158-165.
7. Foley RN, Parfrey PS, Harriett JD el aJ. The prognostic importance of left ventricular geometry in urémie cardiomyopathy. J Am Soc Nephrol 1995; 5(12): 2024-2031.
8. Blacher J, Pannier B, Guerin AP et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32(3): 570-574.
9. Port FK, Hulbert-Shearon TE, Wolfe RA et at. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507-517.
10. Zager PG, Nikolic J, Brown RH el al. 'U' curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998: 54(2): 561-569. (Erratum Kidney Int 1998; 54(4): 1417.)
11. Salem MM. Hypertension in the haemodialysis population: any relationship to 2-years survival?. Nephrol Dial Transplant 1999; 14(1): 125-128.
12. Eliahou HE, laina A, Reisin E, Shapira J. Probability of survival in hypertensive and nonhypertensive patients on maintenance hemodialysis. IsrJMedSci 1977; 13(1): 33-38.
13. Degoulet P, Legrain M, Reach I et al. Mortality risk factors in patients treated by chronic hemodialysis: report of the Diaphane collaborative study. Nephron 1982:31(2): 103-110.
14. Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35-44.
15. Hellerstedt WL, Johnson WJ, Ascher N et al. Survival rates of 2,728 patients with end-stage renal disease. Mayo Clin Proc 1984; 59(11): 776-783.
16. Mailloux LU, Napolitano B, Bellucci AG et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994; 24(4): 622-629.
17. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium-phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31(4): 607-617.
18. Amann K, Gross M-L, London GM, Ritz E. Hyperphosphataemia: a silent killer of patients with renal failure. Nephrol Dial Transplant 1999; 14: 2085-2087.
19. Erslev AJ, Besarab A. Erythropoietin in the pathogenesis and treatment of the anaemia of chronic renal failure. Kidney Int 1997; 51: 622-630.
20. Wakeen M, Zimmerman SW. Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis. Am J Kidney Dis 1998; 32(3): 488-493.
21. Iseki K,Nishime K, Uehara H et al. Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients. Nephron 1996; 72(1): 30-36.
22. Buchanan MR, Brister SJ. A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding. Wien Klin Wochenschr 1999; 111(3): 81-89.
23. Maschio G. Erythropoietin and systemic hypertension. Nephrol Dial Transplant 1995; 10(S2): 74-79.
24. Bergstrom J, Lindholm B. Malnutrition, cardiac disease and mortality: an integrated point of view. Am J Kidney Dis 1998; 32(5): 834-841.
25. Daul AE, Wang XL, Michel MC, Brodde O-E. Arterial hypotension in chronic hemodialysed patients. Kidney Int 1987; 32: 728-735.
26. Parfrey PS, Harnett JD, Griffiths SM et al. Congestive heart failure in dialysis patients. Arch Intern Med 1988: 148: 1519-1525.
27. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engt J Med 1974; 290(13): 697-701.
28. Ibels LS, Stewart JH, Mahony JF et al. Occlusive arterial disease in uraemia and haemodialysis patients and renal transplant recipients: a study of the incidence of arterial disease and of the prevalance of risk factors implicated in the pathogenesis of arteriosclerosis. Q J Med 1977; 46(182): 197-214.
29. Neveling M, Hojer C, Bewermeyer H, Mertens M. B-scan ultrasound findings in the carotid bifurcation area of hemodialysis patients. Ultraschall Med 1992; 13(3): 127-131. (Erratum in Ultraschall Med 1992; 13(4): 202.)
30. Kawagishi T, Nishizawa Y, Konishi T et al. High-resolution B-mode ultrasound ultrasonography in the evaluation of atherosclerosis in uraemia. Kidney Int 1995; 48: 820-826.
31. Rossi A. Bonfante L, Giacomini A et al. Carotid artery lesions in patients with nondiabetic chronic renal failure. Am J Kidney Dis 1996; 27(1): 58-66.
32. Pascazio L, Bianco F, Giorgini A et al. Echo color Doppler imaging of carotid vessels in hemodialysis patients: evidence of high levels of atherosclerotic lesions. Am .1 Kidney Dis 1996; 28(5): 713-720.
33. Jogestrand T, Fehrman-Ekholm I, Angelin B et al. Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantation. J Intern Med 1996; 239(2): 177-180.
34. London GM, Guerin AP, Marchais SJ et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-608.
35. Savage T, Clarke AL, Giles M et al. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant 1998; 13: 2004-2012.
36. Missouris CG, Papavassiliou MB, Khaw K et al. High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. Nephrol Dial Transplant 1998; 13(4): 945-948.
37. Wheeler DC. Cardiovascular disease in patients with chronic renal failure.Lone 1997; 348: 1673-1674.
38. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dix 1996; 27(1): 1-25.
39. Massy ZA, Kasiske BL. Post-transplant hyperlipidaemia: mechanisms and management. J Am Soc Nephrol 1996; 7(7): 971-977.
40. Avram MM, Blaustein DA. Causes, risks and therapy of hyperlipidaemia in chronic dialysis patients. Sem Dialysis 1997; 10(5): 267-271.
41. Jungers P, Massy ZA, Khoa TN er a!. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997; 12(12): 25972602.
42. Shoji T, Nishizawa Y, Kawagishi T et al. Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol 1998; 9(7): 1277-1284.
43. Massy ZA, Mamzer-Bruneel M-F, Chevalier A et al. Carotid atherosclerosis in renal transplant recipients. Nephrol Dial Transplant 1998; 13: 17921798.
44. Koch M, Kutkuhn B, Trenkwalder E et al. Apolipoprotein B, fibrinogen, HDL-cholesterol, and apolipoprotein(a) phenotypes predict coronary disease in hemodialysis patients. J Am Soc Nephrol 1997; 8: 1889-1898.
45. Koch M, Gradaus F, Schoebel F-C et al. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 1997: 12: 1187-1191.
46. London GM, Drucke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997; 51: 1678-1694.
47. Rostand SG, Kirk KA, Rutsky EA. Relationship of coronary risk factors to hemodialysis-associated ischémie heart disease. Kidnev Int 1982; 22(3): 304-308.
48. Malatino LS, Benedetto FA, Mallamaci F et al. Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Nephrol 1999; 12(4): 256-260.
49. Hasselwander O, Young IS. Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure. Med Hypotheses 1997; 49(5): 389-395.
50. Fiorillo C, Oliviero C, Rizzuti G el al. Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis. Clin Chem Lab Med 1998:36(3): 149-153.
51. Zoccali C. C-reative protein and atherosclerosis in dialysis patients. Nephrol Dial Transplant 1998; 13(10): 2710-2711.
52. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55(2): 648-658.
53. Nishizawa Y, Shoji T, Kawagishi T, Morii H. Atherosclerosis in uraemia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. Kidney Int 1997; 62(suppl): S90-S92.
54. Kronenberg F, Neyer U, Lhotta K et al. The low molecular weight Apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: aprospective follow-up. J Am Soc Nephrol 1999; 10: 1027-1036.
55. Kronenberg F, Trenkwalder E, Sturm W et al. LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients. Clin Genet 1997; 52(5): 377-386.
56. Deighan CJ, Caslake MJ. McConnell M et al. Increased atherogenicity of low-density lipoprotein in heavy proteinuria. Nephrol Dial Transplant 1998; 13: 1183-1188.
57. Dantoine TF, Debord J, Charmes JP et al. Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 1998; 9(11): 2082-2088.
58. Liu T, Stern A, Roberts LJ. Morrow JD. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J Biomed Sei 1999; 6(4): 226-235.
59. Symonides B, Januszewicz A, Rowinski O et al. Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis. J Canliovasc Risk 1999; 6(4): 269-272.
60. van den Dorpel MA, Veld AJ, Levi M et al. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients. Arterioscler Thromb Vase Biol 1999; 19(6): 1555-1558.
61. Sakata N, Imanaga Y, Meng J et al. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease. Atherosclerosis 1999; 142(1): 67-77.
62. Bostom AG. Homocysteine: 'expensive creatinine' or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients? J Am Soc Nephrol 2000; 11(1): 149-151.
63. Massy ZA. Chadefaux-Vekemans B, Chevalier A et al. Hyperhomocystinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994; 9: 1103-1108.
64. Jungers P. Chauveau P, Bandin O el al. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab 1997; 23(3-6): 170-173.
65. Bostom AG. Shemin D, Lapane KL et al. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study. Atherosclerosis 1996; 125(1): 91-101.
66. Arnadottir M, Hultberg B, Wahlberg J et al. Serum total homocysteine concentration before and after renal transplantation. Kidney Int 1998; 54(4): 1380-1384.
67. Lee ME, Wang H. Homocysteine and hypomethylation: a novel link to vascular disease. Trends Cardiovasc Med 1999; 9(1-2): 49-54.
68. Blacher J, Demuth K, Guerin AP et al. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vase Biol 1998; 18(4): 535-541.
69. Seman LJ, McNamara JR, Schaefer EJ. Lipoprotein(a), homocysteine. and remnant-like particles: emerging risk factors. Curr Opin Cardiol 1999; 14(2): 186-191.
70. Shemin D, Lapane KL, Bausserman L el al. Plasma total homocysteine and hemodialysis access thrombosis; a prospective study. J Am Soc Nephrol 1999; 10(5): 1095-1099.
71. Manns BJ, Burgess ED, Parsons HG et al. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 1999; 55(1): 315-320.
72. Robinson K, Gupta A, Dennis V et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996; 94(11): 2743-2748.
73. Bostom AG. Shemin D. Verhoef P et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: aprospective study. Arterioscler Thromb Vase Biol 1997; 17(11): 2554-2558.
74. Bostom AG. Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997:52(1): 10-20.
75. Ducloux D, Motte G. Challier B et al. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol 2000; 11(1): 134-137.
76. Jungers P. Joly D. Massy Z et al. Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients. Nephrol Dial Transplant 1999; 14(12): 2903-2906.
77. Suliman ME. Divino FJ, Barany P el al. Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients. J Am Soe Nephrol 1999; 10(6): 1287-1296.
78. Massy ZA. Reversal of hyperhomocyst(e)inaemia in chronic renal failure: is folic or folinic acid the answer? Nephrol Dial Transplant 1999; 14(12): 2810-2812.
79. Andreotti F, Burzotta F. Manzoli A, Robinson K. Homocysteine and risk of cardiovascular disease. J Thromh Thrombolysis 2000; 9(1): 13-21.
80. Rocco MV, Makoff R. Appropriate vitamin therapy for dialysis patients. Sem Dialysis 1997; 10(5): 272-277.
81. Kramer W, Wizemann V, Mandelbaum AP, Ritz E. Cardiological problems in uraemic patients. In: Cameron S, Davison AM, Grunfeld J-P cl al. Eds. Oxford textbook of clinical nephrology. Oxford: Oxford Medical Publications, 1992; 1264-1278.
82. Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993; 44: 617-621.
83. Sinha SK. Coronary angiography and coronary artery by-pass grafts in diabetics. Diabetes Res Clin Pract 1996; 30(suppl): 89-92.
84. Schwarz U, Buzello M, Ritz E et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15(2): 218-223.
85. Goldsmith DJ, Covic A, Sambrook PA, Ackrill P. Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron 1997; 77(1): 37-43.
86. Lazarus JM, Lowrie EG, Hampers CL, Merrill JP. Cardiovascular disease in urémie patients on hemodialysis. Kidney Int 1975; (suppl 2): 167-175.
87. Goodman WG.Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342(20): 1478-1483.
88. Koch M, Kutkuhn B, Grabensee B, Ritz E. Apolipoprotein A, fibrinogen, age and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant 1997: 12: 2603-2611.
89. Morbini P, Dal Bello B, Arbustini E. Coronary artery inflammation and thrombosis in Wegener's granulomatosis- polyarteritis nodosa overlap syndrome. G Ital Cardiol 1998; 28(4): 377-382.
90. Frustaci A, Gentiloni N, Chimenti C et al. Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy. Chest 1998; 114(5): 1484-1489.
91. Nobrega TP, Klodas E, Breen JF el al. Giant coronary artery aneurysms and myocardial infarction in a patient with systemic lupus erythematosus. Cathet Cardiovasc Diagn 1996; 39(1): 75-79.
92. Badui E, Rangel A, Ramos MA et al. Acute myocardial infarction with normal coronary arteries as initial manifestation of polyarteritis nodosa: a case report (in Spanish). Arch Inst Cardiol Mex 1997; 67(5): 411-413.
93. Takahashi M. Inflammatory diseases of the coronary artery in children. Coron Artery Dis 1993:4(2): 133-138.
94. Drogue M, Vergnon JM, Wintzer B el al. Prinzmetal's angina pectoris revealing aneurysm of the right coronary artery during evolution of ChurgStrauss syndrome [letter]. Chest 1993; 103(3): 978.
95. Tsukamoto S, Ohira M, Okumura H et al. Bilateral common iliac artery aneurysms secondary to fibromuscular dysplasia accompanied with a coronary aneurysm: a case report. J Cardiovasc Surg (Torino) 1995; 36(6): 587-590.
96. Christ M, Bechtel U, Schnaack S et al. Aneurysms of coronary arteries in a patient with adult polyeystic kidney disease: arteriosclerosis or involvement by the primary disease? Clin Investis 1993; 71(2): 150-152.
97. Adubofour K.Sidaway L, Glatter T. Coronary artery aneurysms in association with adult polyeystic kidney disease. Am Heart J 1994; 127(5): 1411-1413.
98. Hadimeri H, Lamm C, Nyberg G. Coronary aneurysms in patients with autosomal dominant polyeystic kidney disease. J Am Soc Nephrol 1998; 9(5): 837-841.
99. Schwartzkopff B, Motz W, Frenzel H et al. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88(3): 993-1003.
100. Weber KT, Sun Y. Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994; 23(6): 869877.
101. Tornig J, Gross M-L, Simonaviciene A et al. Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure. J Am Soc Nephrol 1999; 10(1): 77-83.
102. Saffitz JE, Saz.ama K. Roberts WC. Amyloidosis limited to small arter-les causing angina pectoris and sudden death. Am J Cardiol 1983; 51(7): 1234-1235.
103. Coates T, Kirkland GS, Dymock RB et ai. Cutaneous necrosis from calcifie uremie arteriolopathy. Am J Kid Dis 1998; 32(3): 384-391.
104. Maclean C, Brahn E. Systemic lupus erythematosus: calciphylaxis induced cardiomyopathy. J Rheumatology 1995; 22: 177-179.
105. Rostand SG, Gretes JC, Kirk KA et al. Ischemie heart disease in patients with uraemia undergoing maintenance hemodialysis. Kidney Int 1979; 16(5): 600-611.
106. Rostand SG, Kirk KA, Rutsky EA. The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implications for management. Contrib Nephrol 1986; 52: 34-41.
107. Tornig J, Amann K, Ritz E et al. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol 1996; 7(5): 667-675.
108. van Guldener C, Lambert J, Janssen MJ et al. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 1997; 12(suppl 2): 14-18.
109. Narita M, Kurihara T, Sindoh T et al. Characteristics of myocardial ischemia in patients with chronic renal failure and its relation to cardiac sympathetic activity. Kaku Igaku 1999; 36(9): 979-987.
110. Amann K, Mall G, Ritz E. Myocardial interstitial fibrosis in uraemia: is it relevant? Nephrol Dial Transplant 1994; 9: 127-128.
111. Raine AE, Seymour AM, Roberts AF et al. Impairment of cardiac function and energetics in experimental renal failure. J Clin Invest 1993; 92(6): 2934-2940.
112. Bogren HG, Klipstein RK, Underwood RS, Longmore DB. The function of the aorta in ischemie heart disease: a magnetic resonance and angiographie study of aortic compliance and blood flow patterns. Am Heart J 1989; 118: 234-247.
113. O'Rourke M, Gallagher DE. Pulse wave analysis. J Hypertension 1996; 14(S5):S147-S157.
114. Pidgeon GB, Lynn KL, Bailey RR, Robson RA. Coronary angiography prior to renal transplantation. Nephrology 1995; 1: 59-64.
115. Jassal SV, Douglas JF, Stout RW. Prevalence of central autonomie neuropathy in elderly dialysis patients. Nephrol Dial Transplant 1998; 13(7): 1702-1708.
116. Wizemann V. Coronary artery disease in dialysis patients. Nephron 1996; 74(4): 642-651.
117. Ojanen S, Koobi T, Korhonen P et al. QRS amplitude and volume changes during hemodialysis. Am J Nephrol 1999; 19: 423-427.
118. George SK, Singh AK. Current markers of myocardial ischemia and their validity in end-stage renal disease. Curr Opin Nephrol Hypertens 1999; 8(6): 719-722.
119. Porter GA, Norton T, Bennett WB. Troponin T, a predictor of death in chronic haemodialysis patients. Eur Heart J 1998; 19(suppl N): N34-N37.
120. Morton AR, Collier CP, Ali N, Dagnone LE. Cardiac troponin I in patients receiving renal replacement therapy. Am Soc Artif Intern Organs J 1998; 44(5): M433-M435.
121. Roppolo LP, Fitzgerald R, Dillow J et al. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veterans Hospital: a pilot study. J Am Coll Cardiol 1999; 34(2): 448-454.
122. Parry DM, Krahn J, Leroux M, Dalton J. False positive analytical interference of cardiac troponin I assays: an important consideration for method selection. Clin Biochem 1999; 32(8): 667-669.
123. Apple FS, Ricchiuti V, Voss EM et al. Expression of cardiac troponin T isoforms in skeletal muscle of renal disease patients will not cause falsepositive serum results by the second generation cardiac troponin T assay. Eur Heart J 1998; 19(suppl N): N30-N33.
124. Mockel M, Schindler R, Knorr Letal. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant 1999; 14(6): 1489-1495.
125. Pochmalicki G, Jan F, Fouchard 1 et al. Frequency of painless myocardial ischemia during hemodialysis in 50 patients with chronic kidney failure. Arch Mal Coeur Vaiss 1990; 83(11): 1671-1675.
126. Kremastinos D, Paraskevaidis I, Voudiklari S et al. Painless myocardial ischemia in chronic hemodialysed patients: a real event? Nephron 1992; 60(2): 164-170.
127. Wizemann V. Coronary artery disease in dialysis patients. Contrib Nephrol 1998; 124: 1-9.
128. Khauli RB, Steinmuller DR, Novick AC et al. A critical look at survival of diabetics with end-stage renal disease: transplantation versus dialysis therapy. Transplantation 1986; 41(5): 598-602.
129. Schnuelle P, Lorenz D, Trede M et al. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998; 9(11): 2135-2141.
130. Marwick TH, Steinmuller DR, Underwood DA et al. Ineffectiveness of dipyrtdamole spect thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 1990; 49(1): 100-103.
131. Marwick TH, Cain P. Screening for coronary artery disease. Med Clin North Am 1999; 83(6): 1375-13vi.
132. Boudreau RJ, Strony JT, deCret RP et al. Perfusion thallium imaging of type I diabetic patients with end-stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology 1990; 175: 103-105.
133. Le A, Wilson R, Douek K et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994; 24(1): 65-71.
134. Covic A, Goldsmith DJ, Georgescu G et al. Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 1996; 45(2): 104-110.
135. McGregor E, Jardine AG, Murray LS et al. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 1998; 13(6): 1499-1505.
136. McGregor E, Stewart G, Rodger RS, Jardine AG. Early echocardiographic changes and survival following renal transplantation. Nephrol Dial Transplant 2000; 15(1): 93-98.
137. ReisG, Marcovitz PA, Leichtman AB et al. Usefulness of dobutamine stress-echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 1995; 75: 707-710.
138. Stanford W, Thompson BH. Imaging of coronary artery calcification: its importance in assessing atherosclerotic disease. Radial Clin North Am 1999; 37(2): 257-272.
139. Callister TQ, Raggi P, Cooil B et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998; 339(27): 1972-1978.
140. Terman DS, Alfrey AC, Hammond WS et al. Cardiac calcification in uraemia: a clinical, biochemical and pathologic study. Am J Med 1971 ; 50: 744-755.
141. Rostand SG, Sanders PC, Kirk KA et al. Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 1988; 85: 651-657.
142. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27(3): 394-401.
143. Hatada K, Sugiura T, Nakamura S et al. Coronary artery diameter and left ventricular function in patients on maintenance hemodialysis treatment: comparison between diabetic and nondiabetic patients. Nephron 1998; 80(3): 269-273.
144. Goldsmith DJ. Coronary artery calcification on computed tomography. Lancet 1998; 351: 447-448.
145. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27(3): 394-401.
146. Utsunomiya M. Angiographie study of stenosis and calcification of coronary vessels in long-term dialysis patients: examination of risk factors for coronary calcification. Nippon Jinzo Gakkai Shi 1996; 38(4): 155-163.
147. Lip GY, Rathore VS, Katira R et al. Changes in renal function with percutaneous transluminal coronary angioplasty. fnt J Cardiol 1999; 70(2): 127-131.
148. Le A, Wilson R, Douek K et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994; 24: 65-71.
149. Nally JVJ. Cardiac disease in chronic uraemia: investigation. Adv Ren Replace Ther 1997; 4(3): 225-233.
150. Lewis MS, Wilson RA, Walker K et al. Factors in cardiac risk stratifi-cation of candidates for renal transplant. J Cardiovasc Risk 1999; 6(4): 251 255.
151. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute tnyocardial infarction among patients on long-term dialysis. N Engl J Med 1998:339(12): 799-805.
152. Chertow GM, Normand S-LT, Suva LR, McNeil BJ. Survival after acute myocardial infarction in patients with end-stage renal disease: results from the co-operative cardiovascular project. Am J Kidney Dis 2000; 35(6): 1044-1051.
153. Hase H, Joki N, Saijyo T et al. Long-term outcome of coronary events in hcmodialysis patients younger and older than 65 years of age. Nippon Jinzo Gakkai Shi 1999; 41(8): 747-753.
154. de Lemos JA, Hillis LD. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 1996; 7(10): 2044-2054.
155. Massy ZA. Ma JZ, Louis TA, Kasiske BL. Lipid-lowering therapy in patients with renal disease. Kidney Int 1995; 48: 188-198.
156. Anon. Effects of an angiotensin-converting-enzyme inhibitor, ramipril. on cardiovascular events in high-risk patients. N Engl J Med 2000; 342(3): 145-153.
157. Mallick NP. Berlyne GM. Arterial calcification after vitamin D therapy in hyperphosphataemic renal failure. Lancet 1968; i: 1316-1320.
158. Cohen M. Demers C, Gurfinkel EP et al. A comparison of low-molecular-weight hcparin with unfractionated heparin for unstable coronary artery disease. N Engt J Med 1997; 337: 447-452.
159. Cohen M. Treatment of unstable angina: the role of platelet inhibitors and anticoagulants. J Invasive Cardiol 1999; 11(3): 147-159.
160. Klinkhardt U, Kirchmaier CM, Westrup D et al. Ex vivo-in vitro interaction between aspirin, clopidogrel, and the glycoprotein lib/IIia inhibitors abciximab and SR121566A. Clin Pharmacol Ther 2000; 67(3): 305-313.
161. Lincoff AM. Califf RM, Topol EJ. Platelet glycoprotein Ilb/IIIa receptor blockade in coronary artery disease. J Am Col! Cardiol 2000; 35(5): 1103-1115.
162. Noris M, Benigni A, Boccardo P et al. Enhanced nitric oxide synthesis in uraemia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993; 44: 445-450.
163. Bath PMW. Missouris CG. Buckenham T, MacGregor GA. Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sei 1994; 87: 253-257.
164. Winkler J, Fuchs J, Morduchowicz G el al. Circulating aggregated platelets, number of platelets per aggregate and platelet size in chronic dialysis patients. Nephron 1997; 77(1): 44-47.
165. Le Feuvre C. Angioplasty and stenting in patients with renal disease. Heart 2000; 83(1): 7-8.
166. Kober G, Vallbracht C, Giesecke Retal. Transluminal coronary angioplasty in patients with chronic kidney failure. Dtsch Med Wochenschr 1985; 110(4): 129-134.
167. Kahn JK. Rutherford BD, McConahay DR et al. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990; 119(3 Pt 1): 484-489.
168. De Meyer M. Wyns W, Dion R et al. Myoeardial revascularization in patients on renal replacement therapy. Clin Nephrol 1991; 36(3): 147-151.
169. Takeshita S. Yamaguchi T, Isshiki T et al. Percutaneous transluminal coronary angioplasty and coronary bypass grafting for refractory angina in chronic dialysis patients. J Cardiol 1992; 22(2-3): 383-390.
170. Vaitkus PT, Guidera SA. Percutaneous transluminal coronary angioplasty in patients undergoing chronic dialysis. J Interv Cardiol 1993; 6(4): 293-296.
171. Reusser LM, Osborn LA, White HJ et al. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol 1994:73(13): 965-967.
172. Ahmed WH.Shubrooks SJ.GibsonCM et al. Complications and longterm outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994; 128(2): 252-255.
173. Rinehart AL. Herzog CA, Collins AJ et al. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995; 25(2): 281-290.
174. Koyanagi T, NishidaH, Kitamura M et al. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg 1996: 61(6): 1793-1796.
175. Gradaus F, Schoebel FC, Ivens K et al. Rate of restenosis after PTCA in patients with terminal renal failure: a quantitative coronary angiography study. Z Kardiol 1997; 86(5): 373-379.
176. Kikuchi Y. Sakurada T, Koshima R, Kusajima K. Minimally invasive coronary artery bypass grafting and percutaneous coronary angioplasty in the patient with left main disease and chronic renal failure. Nippon Kvobii Geka Gakkai Zasshi 1997; 45(11): 1858-1861.
177. Schoebel FC. Gradaus F. Ivens K cl cil. Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a casecontrol study using quantitative coronary angiography. Heart 1997; 78(4): 337-342.
178. Simsir SA, Kohlman-Trigoboff D. Flood R et al. A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on hemodialysis. Cardiovasc Surg 1998; 6(5): 500-505.
179. Sanai T, Kimura G, Inenaga T et al. Efficacy of percutaneous transluminal coronary angioplasty for patients on hemodialysis: comparison with those not on dialysis. Am J Nephrol 1999; 19(1): 38-44.
180. Ferguson ER, Hudson SL, Diethelm AG et al. Outcome after myocardial revascularization and renal transplantation: a 25-year single-institution experience. Ann Surg 1999; 230(2): 232-241.
181. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidnev lut 1999; 56(1): 324-332.
182. Ohmoto Y, Ayabe M.Hara K el al. Long-term outcome of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in patients with end-stage renal disease. Jpn Circ J 1999; 63(12): 981-987.
183. de Lemos JA. Hillis LD. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 1996; 7(10): 2044-2054.
184. Versaci F. Gaspardone A. Tomai F et al. A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engt J Med 1997; 336: 817-822.
185. Aronson D, Bloomgarden Z. Rayfield EJ. Potential mechanisms promoting
186. Asakura Y, Suzuki M, Nonogi H et al. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM). J Cardiovasc Risk 1998; 5(5-6): 331-334.
187. Moreno PR. Fallon JT, Murcia AM et al. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabeticpatients . J Am Coll Cardiol 1999; 34(4): 1045-1049.
188. Tabet S, Le Feuvre C, Dambrin G et al. Coronary angioplasty in hemodialysis patients. Arch Mal Coeur Vaiss 2000; 93(7): 807-812,
189. Blum U, Hauer M, Krumme B. Percutaneous revascularization of renal artery stenosis: balloon angioplasty vs. stent implantation. Radiologe 1999: 39(2): 135-143.
190. Van d V, Kaatee R. Beutler JJ et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353: 282-286.
191. Rao V, Weisel RD, Buth KJ et al. Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. Circulation 1997: 96(9suppl): 11-43.
192. Anderson RJ, O'Brien M. MaWhinney S et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study No 5. Kidney Int 1999; 55(3): 1057-1062.
193. Chertow GM, Lazarus JM, Christiansen CL et al. Preoperative renal risk stratification. Circulation 1997; 95(4): 878-884.
194. Chertow GM, Levy EM, Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104(4): 343-348.
195. Anderson RJ, O'Brien M, MaWhinney S et al. Mild renal failure is associated with adverse outcome after cardiac valve surgery. Am J Kidney Dis 2000; 35(6): 1127-1134.
196. Ogg CS, Cameron JS. Cardiovascular surgery and the kidney. Guys Hasp Rep 1969; 118(1): 85-103.
197. Menzoian JO, Davis RC. Idelson BA et al. Coronary artery by-pass surgery and renal transplantation: a case report. Ann Surg 1974; 179(1): 63-64.
198. Sakurai H, Ackad A, Friedman HS et al. Aorto-coronary bypass graft surgery in a patient on home hemodialysis. Clin Nephrol 1974:2(5): 208-210.
199. Ko W, Kreiger KH, Isom OW. Cardiopulmonary bypass procedures in dialysis patients. Ann Thorac Surg 1993; 55(3): 677-684.
200. Nakayama Y, Sakata R, Ura M, Miyanioto TA. Coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 1999; 68(4): 1257-1261.
201. Pitt B, Waters D, Brown WV el al. Aggressive lipid lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999; 341: 70-76.
202. Manske CL, Wang Y, Rector T et aJ. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340:998-1002.
203. Ritz E, Amann K, Fliser D. The sympathetic nervous system and the kidney: its importance in renal diseases. Blood Press 1998; Suppl 3: 14-19.
204. Donmez A. Kayhan Z, Pirat A, Sekerci S. Anesthetic management of coronary artery bypass operation in renal transplant recipients. Transplant Proc 1998; 30(3): 790-792.
205. Gotou K, Kimura F, Kimura N et al. The anesthetic management of patients in chronic renal failure for coronary artery bypass surgery without cardiopulmonary bypass. Masui 1997; 46(12): 1609-1614.
206. Schmidt R, Weidemann H, Weihermuller K, Bucherl ES. Heart surgery in terminal kidney failure and dialysis dependent patients: intraoperative hemofiltration for the prevention of hyperhydration. Zentralbl Chir 1989; 114(5): 306-312.
207. Saito T, Terada Y, Fukuda S et al. The perioperative management of dialysis for patients undergoing coronary artery bypass surgery with chronic renal failure. Kyobu Geka 1991; 44(10): 833-837.
208. Murkin JM, Murphy DA, Finlayson DC, Waller JL. Hemodialysis during cardiopulmonary bypass: report of 12 cases. Anesth Analg 1987; 66(9): 899-901.
209. Karzai W, Priebe HJ. Oxygen consumption in hemodialysis patients undergoing cardiopulmonary bypass. J Cardiothorac Vase Anesth 1998; 12(4): 415-417.
210. Stahle E, Tammelin A, Bergstrom R et al. Sternal wound complications: incidence, microbiology and risk factors. Eur J Cardiothorac Surg 1997; 11(6): 1146-1153.
211. John R, Choudhri AF, Weinberg AD el al. Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg 2000; 69(1): 30-35.
212. Campeau L, Hunninghake DB, Knatterud GL et al. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators. Circulation 1999:99(25): 3241-3247.
213. Kaneko T, Horio M, Sugiura T et al. Histological change of coronary artery bypass graft in a maintenance hemodialysis patient. Nephron 1994; 66(1): 110-111.
214. Jahangiri M, Kovacs IB, Ridler CD el al. Coronary artery surgery is associated with different forms of atherogenic lipoprotein modifications. Ann Thorac Surg 1999; 67(3): 652-656.
215. Coller BS. Potential non-glycoprotein Ilb/IIIa effects of abciximab./4m Heart J 1999; 138(1 Pt 2): S1-S5.
216. Coleman KR, Braden GA, Willingham MC, Sane DC. Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (alphavbeta3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ Res 1999; 84(11): 1268-1276.
217. Christiansen S, Splittgerber FH, Marggraf G et al. Results of cardiacoperations in five kidney transplant patients. Thorac Cardiovasc Surg 1997; 45(2): 75-77.
218. Jahangiri M, Wright J, Edmondson S, Magee P. Coronary artery bypass graft surgery in dialysis patients. Heart 1997; 78(4): 343-345.
219. Dresler C. Uthoff K, Wahlers T et al. Open heart operations after renal transplantation. Ann Thorac Surg 1997; 63(1): 143-146.
220. Nakayama Y, Sakata R, Ueyama K et al. Cardiac surgery in patients with chronic renal failure on maintenance dialysis. Nippon Kyobu Geka GakkaiZasshi 1997; 45(10): 1661-1666.
221. Manske CL, Nelluri S, Thomas W, Shumway SJ. Outcome of coronary artery bypass surgery in diabetic transplant candidates. Clin Transplant 1998; 12(2): 73-79.
222. Sawada Y, Morimoto T, Matsuyama N et al. Coronary artery bypass graft surgery in dialysis patient. Jpn J Thorac Cardiovasc Surg 1998; 46(10): 983-986.
223. Simsir SA, Kohlman-Trigoboff D, Flood Retal.A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on hemodialysis. Cardiovasc Surg 1998; 6(5): 500-505.
224. Dagenais F, Voisine P, Normandin L et al. Cardiac surgery in renal transplant patients: apropos of 24 cases. Ann Chir 1998; 52(8): 834-839.
225. Castelli P, Condemi AM, Munari M. Immediate and long-term results of coronary revascularization in patients undergoing chronic hemodialysis. Eur J Cardiothorac Surg 1999; 15(1): 51-54.
226. Labrousse L, de Vincentiis C, Madonna F et al. Early and long term results of coronary artery bypass grafts in patients with dialysis dependent renal failure. Eur J Cardiothorac Surg 1999; 15(5): 691-696.
227. Suehiro S. Shibata T, Sasaki Y et al. Cardiac surgery in patients with dialysis-dependent renal disease. Ann Thorac Cardiovasc Surg 1999; 5(6): 376-381.
228. Tanaka H, Suzuki K, Hida Y et al. Emergency coronary artery bypass grafting in dialysis patients. Kyobu Geka 1999; 52(8 suppl): 683-687.
229. Horst M, Mehlhorn U, Hoerstrup SP et al. Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg 2000; 69(1): 96-101.